» Articles » PMID: 34183063

Novel Insights into the Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Two Sides of the Same Coin

Overview
Journal Microbiome
Publisher Biomed Central
Specialties Genetics
Microbiology
Date 2021 Jun 29
PMID 34183063
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leptin-deficient ob/ob mice and leptin receptor-deficient db/db mice are commonly used mice models mimicking the conditions of obesity and type 2 diabetes development. However, although ob/ob and db/db mice are similarly gaining weight and developing massive obesity, db/db mice are more diabetic than ob/ob mice. It remains still unclear why targeting the same pathway-leptin signaling-leads to the development of two different phenotypes. Given that gut microbes dialogue with the host via different metabolites (e.g., short-chain fatty acids) but also contribute to the regulation of bile acids metabolism, we investigated whether inflammatory markers, bacterial components, bile acids, short-chain fatty acids, and gut microbes could contribute to explain the specific phenotype discriminating the onset of an obese and/or a diabetic state in ob/ob and db/db mice.

Results: Six-week-old ob/ob and db/db mice were followed for 7 weeks; they had comparable body weight, fat mass, and lean mass gain, confirming their severely obese status. However, as expected, the glucose metabolism and the glucose-induced insulin secretion were significantly different between ob/ob and db/db mice. Strikingly, the fat distribution was different, with db/db mice having more subcutaneous and ob/ob mice having more epididymal fat. In addition, liver steatosis was more pronounced in the ob/ob mice than in db/db mice. We also found very distinct inflammatory profiles between ob/ob and db/db mice, with a more pronounced inflammatory tone in the liver for ob/ob mice as compared to a higher inflammatory tone in the (subcutaneous) adipose tissue for db/db mice. When analyzing the gut microbiota composition, we found that the quantity of 19 microbial taxa was in some way affected by the genotype. Furthermore, we also show that serum LPS concentration, hepatic bile acid content, and cecal short-chain fatty acid profiles were differently affected by the two genotypes.

Conclusion: Taken together, our results elucidate potential mechanisms implicated in the development of an obese or a diabetic state in two genetic models characterized by an altered leptin signaling. We propose that these differences could be linked to specific inflammatory tones, serum LPS concentration, bile acid metabolism, short-chain fatty acid profile, and gut microbiota composition. Video abstract.

Citing Articles

The UBR5 protein facilitates mesangial cell hypertrophy and glycolysis induced by high glucose by increasing the phosphorylation levels of AKT.

Liao L, Xu Q, Xu J, Chen J, Liu W, Chen W Acta Diabetol. 2025; .

PMID: 39945887 DOI: 10.1007/s00592-025-02464-9.


Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias.

Bahrami P, Aromolaran K, Aromolaran A J Cell Physiol. 2025; 240(2):e70012.

PMID: 39943721 PMC: 11822244. DOI: 10.1002/jcp.70012.


Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.

Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F Biomolecules. 2025; 15(1).

PMID: 39858515 PMC: 11763965. DOI: 10.3390/biom15010121.


Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor.

Qi Y, Ma Y, Duan G Int J Mol Sci. 2025; 25(24.

PMID: 39769418 PMC: 11727972. DOI: 10.3390/ijms252413656.


Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.


References
1.
Anhe F, Jensen B, Varin T, Servant F, Van Blerk S, Richard D . Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nat Metab. 2020; 2(3):233-242. DOI: 10.1038/s42255-020-0178-9. View

2.
Zeng Q, Li D, He Y, Li Y, Yang Z, Zhao X . Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci Rep. 2019; 9(1):13424. PMC: 6748942. DOI: 10.1038/s41598-019-49462-w. View

3.
Wauman J, Zabeau L, Tavernier J . The Leptin Receptor Complex: Heavier Than Expected?. Front Endocrinol (Lausanne). 2017; 8:30. PMC: 5318964. DOI: 10.3389/fendo.2017.00030. View

4.
Chiang J . Bile acid metabolism and signaling in liver disease and therapy. Liver Res. 2017; 1(1):3-9. PMC: 5663306. DOI: 10.1016/j.livres.2017.05.001. View

5.
Kashani A, Brejnrod A, Jin C, Kern T, Madsen A, Holm L . Impaired glucose metabolism and altered gut microbiome despite calorie restriction of ob/ob mice. Anim Microbiome. 2021; 1(1):11. PMC: 7807779. DOI: 10.1186/s42523-019-0007-1. View